The University of Eastern Finland is a university in Finland with campuses in Joensuu and Kuopio. It was formed in 2010 by a merger of two previously independent universities.

During the past decade, University of Eastern Finland conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Eastern Finland" #1 sponsor was "University of Eastern Finland" with 25 trials, followed by "Marjukka Kolehmainen" with 5 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Ottawa Heart Institute Research Corporation" with 3 trials sponsored and "AC Immune SA" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Eastern Finland" #1 collaborator was "Kuopio University Hospital" with 12 trials as a collaborator, "Kuopio Research Institute of Exercise Medicine" with 4 trials as a collaborator, "University of Copenhagen" with 4 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator and "The Finnish Funding Agency for Technology and Innovation (TEKES)" with 3 trials as a collaborator. Other collaborators include 78 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "University of Eastern Finland" are "Dementia" (3 trials), "Heart Failure" (3 trials), "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials) and "Blood Pressure" (2 trials). Many other conditions were trialed in "University of Eastern Finland" in a lesser frequency.

Most popular intervention types in "University of Eastern Finland" are "Other" (16 trials), "Behavioral" (9 trials), "Dietary Supplement" (8 trials), "Drug" (7 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Gantenerumab" (3 trials), "Advanced Imaging" (2 trials), "Standard Imaging" (2 trials) and "Vitamin D3" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Eastern Finland" are 38 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University of Eastern Finland". 1 are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in University of Eastern Finland, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Eastern Finland, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 29 trials that are defined as “Not Applicable".